NEW YORK (GenomeWeb News) – Rodney Markin has joined Trovagene's board of directors, and Chris McGuigan has resigned from the company's board to focus on other opportunities, Trovagene said this week.

Markin is chairman of Transgenomic, chief technology officer and associate vice chancellor for business development at the University of Nebraska Medical Center, and a professor of pathology and microbiology and surgery at the university.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.